Syros Pharmaceuticals, Inc. (SYRS)
OTCMKTS · Delayed Price · Currency is USD
0.0004
0.00 (0.00%)
May 6, 2026, 3:47 PM EST

Syros Pharmaceuticals Statistics

Total Valuation

SYRS has a market cap or net worth of 10,733.

Market Cap10,733
Enterprise Value n/a

Important Dates

The last earnings date was Monday, March 2, 2026.

Earnings Date Mar 2, 2026
Ex-Dividend Date n/a

Share Statistics

SYRS has 26.83 million shares outstanding.

Current Share Class 26.83M
Shares Outstanding 26.83M
Shares Change (YoY) n/a
Shares Change (QoQ) +0.17%
Owned by Insiders (%) 0.05%
Owned by Institutions (%) 1.99%
Float 26.82M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.03
PB Ratio -0.00
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.25

Current Ratio 2.25
Quick Ratio 2.05
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -0.60
Interest Coverage -20.92

Financial Efficiency

Return on equity (ROE) is -776.96% and return on invested capital (ROIC) is -94.28%.

Return on Equity (ROE) -776.96%
Return on Assets (ROA) -59.88%
Return on Invested Capital (ROIC) -94.28%
Return on Capital Employed (ROCE) -197.02%
Weighted Average Cost of Capital (WACC) 6.99%
Revenue Per Employee 5,676
Profits Per Employee -1.44M
Employee Count68
Asset Turnover 0.00
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -98.77% in the last 52 weeks. The beta is 1.26, so SYRS's price volatility has been higher than the market average.

Beta (5Y) 1.26
52-Week Price Change -98.77%
50-Day Moving Average 0.00
200-Day Moving Average 0.00
Relative Strength Index (RSI) 53.13
Average Volume (20 Days) 5,155

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 2.75

Income Statement

In the last 12 months, SYRS had revenue of 386,000 and -97.82 million in losses. Loss per share was -2.66.

Revenue386,000
Gross Profit -88.25M
Operating Income -111.52M
Pretax Income -97.82M
Net Income -97.82M
EBITDA -110.18M
EBIT -111.52M
Loss Per Share -2.66
Full Income Statement

Balance Sheet

The company has 58.28 million in cash and 60.23 million in debt, with a net cash position of -1.95 million or -0.07 per share.

Cash & Cash Equivalents 58.28M
Total Debt 60.23M
Net Cash -1.95M
Net Cash Per Share -0.07
Equity (Book Value) -11.12M
Book Value Per Share -0.41
Working Capital 35.54M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -100.02 million and capital expenditures -38,000, giving a free cash flow of -100.05 million.

Operating Cash Flow -100.02M
Capital Expenditures -38,000
Depreciation & Amortization 1.34M
Net Borrowing -3,000
Free Cash Flow -100.05M
FCF Per Share -3.73
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -28,891.71%
Pretax Margin -25,340.67%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

SYRS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -31.77%
Shareholder Yield -31.77%
Earnings Yield -911,348.18%
FCF Yield -932,209.07%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on September 19, 2022. It was a reverse split with a ratio of 0.1.

Last Split Date Sep 19, 2022
Split Type Reverse
Split Ratio 0.1

Scores

SYRS has an Altman Z-Score of -15.52. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -15.52
Piotroski F-Score n/a